Obesity surgery

Metabolic and Weight-Loss Surgery Compared with GLP-1 Medicine in Reducing Death and Heart Problems in People with Obesity and Type 2 Diabetes

GLP-1 Therapies Weekly Brief ↗PubMed ↗DOI ↗OA ↗

Updated

Full Text

Full text is available at the source.
View Full Text ↗

Funding

Competing interests

Declarations. Competing interests: The authors declare no competing interests.
PubMed

Related papers

Feb '26
Cardiovascular outcomes of GLP-1 medicines compared to weight-loss surgery: a review and analysis
top 20% journal
journal article
Jan '23
Major heart and blood vessel problems in people with type 2 diabetes comparing weight-loss surgery and GLP-1 drug treatment
top 10% journal
cited by 36 papers
research support, non-u.s. gov't
Jan '26
Heart health and death rates after weight loss surgery compared to GLP-1 hormone treatments
top 20% journal
cited by 5 papers
journal article
Jun '23
Factors linked to how well SGLT-2 inhibitors versus GLP-1 receptor agonists reduce major heart problems in type 2 diabetes
top 2% journal
cited by 28 papers
meta-analysis
Nov '24
How Weight-Loss Surgery and Diabetes Drugs Compare in Heart Health and Survival: A Combined Study
cited by 1 paper
journal article
Aug '21
Heart, death, and kidney outcomes with GLP-1 receptor drugs in type 2 diabetes patients
top 1% journal
cited by 1,295 papers
research support, non-u.s. gov't
Sep '25
Large and small blood vessel outcomes after weight-loss surgery compared to diabetes medicine in people with diabetes and obesity
🏆 top 0.1% journal
cited by 13 papers
journal article
Oct '25
How safe and effective combining two diabetes drugs (SGLT2 inhibitors and GLP-1 receptor agonists) is for people with type 2 diabetes
top 2% journal
cited by 17 papers
systematic review

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the glp-1 therapies brief

issue #52
GLP-1 drugs linked to lower Parkinson's risk in people with type 2 diabetes
yesterday7 studies
issue #51
Semaglutide linked to nearly double the risk of a rare eye condition in people with diabetes
1 week ago7 studies
issue #50
A once-daily pill beat placebo on weight loss — and it wasn't semaglutide
2 weeks ago7 studies
issue #49
GLP-1 drugs work even without weight loss — and scientists are finally mapping why
3 weeks ago7 studies
issue #48
Stop the drug, regain the weight: pooled data puts the average rebound at 7%
4 weeks ago7 studies
issue #47
The brain region that explains why blocking and activating the same receptor both cause weight loss
5 weeks ago7 studies
issue #46
GLP-1 drugs linked to lower depression and bipolar disorder risk in large genetic study
6 weeks ago7 studies
issue #45
Stopping GLP-1 drugs linked to higher depression and anxiety risk in type 2 diabetes patients
7 weeks ago7 studies
issue #44
Tirzepatide cut all-cause mortality by more than half compared to semaglutide in a 47,000-patient study
8 weeks ago7 studies
issue #43
Semaglutide linked to 21% lower psychiatric hospitalization risk in bipolar disorder patients
9 weeks ago7 studies
explore the archive
See more issues from the glp-1 therapies brief